Myelodysplasia Cutis Versus Leukemia Cutis
Overview
Authors
Affiliations
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome.
Grolleau C, Battistella M, Zakine E, Poisot T, Cordoliani F, Mahevas T JAMA Dermatol. 2025; .
PMID: 40072458 PMC: 11904800. DOI: 10.1001/jamadermatol.2025.0034.
Diagnostic approach to leukemia cutis : A differential diagnostic step-by-step algorithm.
Jenei A, Tzankov A Am J Clin Pathol. 2024; 163(3):395-405.
PMID: 39422152 PMC: 11890294. DOI: 10.1093/ajcp/aqae133.
Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms.
Mahevas T, Osio A, Larcher L, Clappier E, Kempf W, Ades L Blood Adv. 2024; 8(12):3293-3298.
PMID: 38621250 PMC: 11226969. DOI: 10.1182/bloodadvances.2023012489.
Prieto-Torres L, Requena L, Rodriguez-Pinilla S Cancers (Basel). 2023; 15(24).
PMID: 38136431 PMC: 10742063. DOI: 10.3390/cancers15245888.
A rare case of late myelodysplasia cutis associated with essential thrombocythemia: A case report.
Fournier S, Mailhot S, Bujold J SAGE Open Med Case Rep. 2022; 10:2050313X221085760.
PMID: 35341103 PMC: 8943643. DOI: 10.1177/2050313X221085760.